Related Experiment Videos
Tissue-engineered grafts matured in the right ventricular outflow tract
Tsukasa Ozawa1, Donald A G Mickle, Richard D Weisel
1Department of Surgery, Division of Cardiovascular Surgery, Toronto General Research Institute, Toronto General Hospital, University of Toronto, Canada.
Cell Transplantation
|May 8, 2004
Summary
Biodegradable scaffolds seeded with smooth muscle cells (SMCs) show potential for repairing pediatric cardiac defects. These engineered tissues integrate well, forming new blood vessels and contractile tissue within the heart.
Area of Science:
- Biomaterials Science
- Cardiovascular Surgery
- Tissue Engineering
Background:
- Pediatric right ventricular outflow tract (RVOT) anomalies require effective repair materials.
- Autologous smooth muscle cell (SMC)-seeded biodegradable scaffolds offer a promising regenerative approach.
Purpose of the Study:
- To evaluate the efficacy of SMC-seeded biodegradable scaffolds for RVOT defect repair in a rat model.
- To assess scaffold degradation, tissue integration, and cellular phenotype changes in vivo.
Main Methods:
- SMCs were seeded onto a novel epsilon-caprolactone-co-L-lactide/poly-L-lactide (PCLA) copolymer scaffold.
- The seeded scaffold was used to repair surgically created RVOT defects in adult rats.
- Histological and mechanical analyses were performed at 8 and 22 weeks post-implantation.
Main Results:
- The PCLA scaffold demonstrated controlled biodegradation with new tissue formation, including elastin and collagen.
- Significant increases in capillary density and cellularity were observed over time.
- Implanted SMCs transitioned from a synthetic to a contractile phenotype, and grafts maintained structural integrity.
- Endothelialization of the graft surface occurred by 8 weeks.
Conclusions:
- SMC-seeded PCLA scaffolds support tissue regeneration and functional adaptation for RVOT repair.
- Further optimization is needed to enhance smooth muscle and elastin content before large-animal studies.